東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Proteomic methods in neuropsychiatri...

Guest, Paul C.

FindBook

Google Book

Amazon

博客來

Proteomic methods in neuropsychiatric research

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Proteomic methods in neuropsychiatric research/ edited by Paul C. Guest.
其他作者:	Guest, Paul C.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xii, 370 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Neuropsychiatry - Research -
電子資源:	http://dx.doi.org/10.1007/978-3-319-52479-5
ISBN:	9783319524795

Proteomic methods in neuropsychiatric research
Proteomic methods in neuropsychiatric research[electronic resource] /edited by Paul C. Guest. - Cham :Springer International Publishing :2017. - xii, 370 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology,9740065-2598 ;. - Advances in experimental medicine and biology.Proteomics, metabolomics, interactomics and systems biology ;974..

Due to continuous technical developments and new insights into the high complexity of neurological diseases, there is an increasing need for the application of proteomic technologies which can yield potential biomarker readouts for improved clinical management as well as for the development of new drugs by struggling pharmaceutical companies. This book describes the step-by-step use of proteomic methods such as two-dimensional gel electrophoresis, multiplex immunoassay, liquid chromatography mass spectrometry (LC-MS) and selective reaction monitoring MS, to increase our understanding of these diseases, with the ultimate aim of improving patient care. The volume will be of high interest to clinical scientists, physicians and pharmaceutical company scientists as it gives insights into the latest technologies enabling the revolution of personalized medicine. It is of direct interest to both technical and bench biomarker scientists as it gives step by step instructions on how to carry out each of the protocols. It is also of interest to researchers as each technique will be presented in the context of a specific neurological disorder, including Alzheimer's disease, multiple sclerosis, autism spectrum disorders, schizophrenia, major depressive disorder and bipolar disorder. Finally, it will also highlight the future research efforts in this field, which are endeavoring to convert proteomic platforms to the form of hand held devices which can be used in a point of care setting and return diagnostic results within the timeframe of a visit to the general practitioner.

ISBN: 9783319524795

Standard No.: 10.1007/978-3-319-52479-5doiSubjects--Topical Terms:

3226399
Neuropsychiatry
--Research

LC Class. No.: RC337

Dewey Class. No.: 616.890072

Proteomic methods in neuropsychiatric research
LDR:02647nmm a2200313 a 4500 001 2092483
003 DE-He213
005 20170330192646.0
006 m d
007 cr nn 008maaau
008 171117s2017 gw s 0 eng d
020 $a 9783319524795 $q (electronic bk.)
020 $a 9783319524788 $q (paper)
024 7 $a 10.1007/978-3-319-52479-5 $2 doi
035 $a 978-3-319-52479-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC337
072 7 $a PSBC $2 bicssc
072 7 $a SCI007000 $2 bisacsh
082 0 4 $a 616.890072 $2 23
090 $a RC337 $b .P967 2017
245 0 0 $a Proteomic methods in neuropsychiatric research $h [electronic resource] / $c edited by Paul C. Guest.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xii, 370 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology, $x 0065-2598 ; $v 974
520 $a Due to continuous technical developments and new insights into the high complexity of neurological diseases, there is an increasing need for the application of proteomic technologies which can yield potential biomarker readouts for improved clinical management as well as for the development of new drugs by struggling pharmaceutical companies. This book describes the step-by-step use of proteomic methods such as two-dimensional gel electrophoresis, multiplex immunoassay, liquid chromatography mass spectrometry (LC-MS) and selective reaction monitoring MS, to increase our understanding of these diseases, with the ultimate aim of improving patient care. The volume will be of high interest to clinical scientists, physicians and pharmaceutical company scientists as it gives insights into the latest technologies enabling the revolution of personalized medicine. It is of direct interest to both technical and bench biomarker scientists as it gives step by step instructions on how to carry out each of the protocols. It is also of interest to researchers as each technique will be presented in the context of a specific neurological disorder, including Alzheimer's disease, multiple sclerosis, autism spectrum disorders, schizophrenia, major depressive disorder and bipolar disorder. Finally, it will also highlight the future research efforts in this field, which are endeavoring to convert proteomic platforms to the form of hand held devices which can be used in a point of care setting and return diagnostic results within the timeframe of a visit to the general practitioner.
650 0 $a Neuropsychiatry $x Research $x Methodology. $3 3226399
650 0 $a Proteomics. $3 600542
650 0 $a Biochemical markers. $3 587592
650 1 4 $a Life Sciences. $3 890838
650 2 4 $a Gene Expression. $3 600530
650 2 4 $a Gene Therapy. $3 600618
700 1 $a Guest, Paul C. $3 3219137
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology. $p Proteomics, metabolomics, interactomics and systems biology ; $v 974. $3 3226398
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-52479-5
950 $a Biomedical and Life Sciences (Springer-11642)